title: Studies on the histogenesis of myxomatous tissue of human coronary lesions.
abstract: Myxomatous tissue is a characteristic component of human coronary artery lesions, found more often in restenotic lesions. It represents a bulky accumulation of stellate-shaped cells of unknown histogenesis that are embedded in a loose stroma. We analyzed 64 atherectomy specimens containing substantial amounts of myxomatous tissue by using immunohistochemistry, in situ hybridization, and electron microscopy techniques. Stellate cells represented a heterogeneous population, sharing features of smooth muscle cells (SMCs), macrophages, as well as antigen-presenting dendritic cells. Like quiescent medial SMCs, the stellate cells in all specimens expressed high levels of SM alpha-actin message and protein and showed heterogeneity with respect to heavy-chain myosin, SM22, desmin, and vimentin. Ultrastructurally, stellate cells resembled SMCs, with some peculiarities that distinguish them from both differentiated and dedifferentiated SMCs. In contrast to quiescent SMCs, the stellate cells expressed high levels of acidic fibroblast growth factor mRNA and protein similar to cells of monocyte/macrophage lineage. However, stellate cells did not express the marker of mature macrophages, HAM56, and were heterogeneous with respect to CD68. Moreover, unlike SMCs, the stellate cells bore some of the major phenotypic markers of dendritic cells: they were S100-positive and showed various reactivity with respect to CD1a and human leukocyte antigen (HLA)-DR. Invasion of myxomatous tissue with CD45RO-positive T lymphocytes was correlated with strong expression of CD1a in these specimens. Stellate cells also expressed a pericyte marker, high-molecular-weight melanoma-associated antigen. We conclude that stellate cells of myxomatous tissue represent a specific phenotype of mesenchymal cells (possibly pericytes), which is activated to express some markers of antigen-presenting cells. These findings suggest involvement of the stellate cells in a local immune response.
authors.affiliation: Department of Experimental Pathology, J.H. Holland Laboratory, American Red Cross, Rockville, Md, USA.
authors.forename: A V
authors.initials: AV
authors.lastname: Tjurmin
authors.forename: N M
authors.initials: NM
authors.lastname: Ananyeva
authors.forename: E P
authors.initials: EP
authors.lastname: Smith
authors.forename: Y
authors.initials: Y
authors.lastname: Gao
authors.forename: M K
authors.initials: MK
authors.lastname: Hong
authors.forename: M B
authors.initials: MB
authors.lastname: Leon
authors.forename: C C
authors.initials: CC
authors.lastname: Haudenschild
mesh_terms: D000199:Actins / Q000032:analysis / Q000235:genetics; D000368:Aged; D017073:Atherectomy; D002467:Cell Nucleus / Q000473:pathology; D003094:Collagen / Q000032:analysis; D003327:Coronary Disease / Q000473:pathology* / Q000601:surgery; D003331:Coronary Vessels / Q000473:pathology*; D003593:Cytoplasm / Q000473:pathology; D003713:Dendritic Cells / Q000276:immunology / Q000473:pathology; D005109:Extracellular Matrix / Q000473:pathology; D016220:Fibroblast Growth Factor 1; D016222:Fibroblast Growth Factor 2 / Q000032:analysis; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D008854:Microscopy, Electron; D008875:Middle Aged; D009232:Myxoma / Q000473:pathology*; D011509:Proteoglycans / Q000032:analysis; D017154:Stromal Cells / Q000473:pathology
chemical_list: D000199:Actins; D011509:Proteoglycans; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1; D003094:Collagen